Lannett Company Revenue and Competitors

Location

$436.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Lannett Company's estimated annual revenue is currently $453.8M per year.(i)
  • Lannett Company's estimated revenue per employee is $973,863
  • Lannett Company's total funding is $436.3M.
  • Lannett Company's current valuation is $68.1M. (January 2022)

Employee Data

  • Lannett Company has 466 Employees.(i)
  • Lannett Company grew their employee count by -2% last year.

Lannett Company's People

NameTitleEmail/Phone
1
Interim VP OperationsReveal Email/Phone
2
VP Business DevelopmentReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
V.P. Reg. & Corp. ComplianceReveal Email/Phone
5
AVP, Project Management and Strategic OperationsReveal Email/Phone
6
VP Global Supply Chain and CDMO ManagementReveal Email/Phone
7
VP Human ResourcesReveal Email/Phone
8
VP Reseach and DevelopmentReveal Email/Phone
9
AVP and Deputy General CounselReveal Email/Phone
10
VP Research and Development, Regulatory and Government AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is Lannett Company?

Lannett Company, Inc manufactures and distributes pharmaceutical products sold under generic names, and historically, has sold them under trade or brand names as well. The Company's general business offices, laboratory, manufacturing, distribution and research and development facilities are located in a 31,000 square foot facility situated on 4.5 acres in northeast Philadelphia, Pennsylvania.

keywords:N/A

$436.3M

Total Funding

466

Number of Employees

$453.8M

Revenue (est)

-2%

Employee Growth %

$68.1M

Valuation

N/A

Accelerator

Lannett Company News

2022-04-20 - Idiopathic Intracranial Hypertension Treatment Market Size ...

... Janssen – Cilag Pharmaceuticals SA, Lannett Company, Medtronic, ... the deficiencies and problems faced by dominant or new companies.

2022-03-30 - Lab Notes: Jazz agrees to multimillion-dollar drug sale ...

Lannett Co. The Trevose-based pharmaceutical company has dosed the first patient in its pivotal clinical trial of biosimilar insulin...

2022-03-22 - LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR ...

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of...

2021-11-03 - Lannett Reports Fiscal 2022 First-Quarter Financial Results; Revises Down Full-year Guidance

PHILADELPHIA, Nov. 3, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today reported financial results for its fiscal 2022 first quarter ended September 30, 2021. "For the quarter, solid sales of several key products contributed to our better than expected topline," said Tim Crew, chief ...

2021-10-28 - Lannett To Report Fiscal 2022 First-quarter Financial Results, Host Conference Call On Wednesday, November 3

PHILADELPHIA, Oct. 28, 2021 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that it will report financial results for its fiscal 2022 first quarter on Wednesday, November 3, 2021, after the market closes. Lannett management will host a conference call that same afternoon at 4:3 ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$160.7M47647%N/A
#2
$109.1M48520%N/A
#3
$151.6M485-2%N/A
#4
$215.3M488-3%N/A
#5
$149.8M4896%N/A